# Coproporphyrine Isomers and Methotrexate Elimination

> **NCT00822432** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 85 (actual)

## Conditions studied

- Central Nervous System Neoplasms
- Lymphoma, Large B-Cell, Diffuse
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Burkitt Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00822432
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2012-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00822432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00822432, "Coproporphyrine Isomers and Methotrexate Elimination". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00822432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*